NUZE

05 / 10

Unitree shares close 460% higher

Unitree’s Shanghai debut made its shares a public-market test for China’s humanoid-robot sector.

Summaries are written by NUZE from the day’s measured coverage across many newsrooms, with founder oversight.

Unitree shares close 460% higher
01

What happened

Unitree Robotics began trading on Shanghai’s STAR Market after raising 6.1 billion yuan in an initial public offering. The Hangzhou-based maker of humanoid and quadruped robots opened far above its offer price and closed at 845 yuan, marking the first mainland China listing by a humanoid-robot maker.

02

Numbers

  • 460%Closing gain over offer price — First day of trading
  • $905 millionRaised in initial public offering — About 6.1 billion yuan
  • 18,000Bipedal robots delivered by July — Across multiple models
  • 278 million yuanNet profit recorded in 2025 — Annual company profit
03

Questions

Q1

What machines does Unitree make?
It sells sensors, automated arms, four-legged robots and human-like machines, and has used dancing, martial arts and backflips to demonstrate them.

Q2

Why did investors focus on robotics?
Beijing treats robotics as a strategic technology sector, while China and the United States compete over robots and AI.

Q3

How profitable was the company?
Unitree recorded net profit of 278 million yuan in 2025, placing it among the few companies in the sector making money.

Q4

What would validate the valuation?
Analysts point to reliable performance and attractive returns from large-scale industrial and commercial deployment, rather than demonstrations, as the key test.
04

Support and opposition

Who supports this, and why

Investment advocates — The debut reflects confidence that Chinese robotics makers can scale manufacturing and develop commercially valuable machines.

Who opposes this, and why

Commercial-use skeptics — Demonstrations must become reliable, profitable large-scale industrial and commercial deployments before valuations can be justified.

05

The catch

The coverage leaves open whether demonstrations will translate into sustained commercial demand and returns.

Large-scale adoption remains unproven.

06

What happens next

Commercial deployment results would test the valuation; no scheduled milestone was identified.

07

Sources

Open in NUZE